IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1217 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1400    
    Printed134    
    Emailed0    
    PDF Downloaded140    
    Comments [Add]    

Recommend this journal

 

 CASE REPORT
Year : 2019  |  Volume : 85  |  Issue : 1  |  Page : 56--59

Successful treatment of metastatic extramammary Paget's disease with pemetrexed monotherapy systemically and 5-fluorouracil topically


1 Department of Oncology, Southern Medical University, Guangzhou; Department of Chemotherapy, Zhongshan People's Hospital, Zhongshan, Guangdong Province, People's Republic of China
2 Department of Chemotherapy, Zhongshan People's Hospital, Zhongshan, Guangdong Province, People's Republic of China
3 Department of Oncology, Southern Medical University, Guangzhou, People's Republic of China

Correspondence Address:
Dr. Hanlin Liang
Department of Chemotherapy, Zhongshan People's Hospital, Zhongshan, Guangdong Province
People's Republic of China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijdvl.IJDVL_171_17

Rights and Permissions

Advanced extramammary Paget's disease does not have a standardized treatment guideline as its incidence is low and has been rarely reported in literature. Here we describe a case of metastatic extramammary Paget's disease successfully treated with topical 5-fluorouracil (5-FU) and systemic pemetrexed. The therapy was safe without any appreciable adverse effects like diarrhea, rash, neutropenia or fatigue; maintaining remission for more than 6 months. Thus, we propose 5-FU and pemetrexed as the first-line therapy for advanced extramammary Paget's disease, especially for aged patients with unresectable skin lesions.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow